Real World Evidence
AI-driven solution applications
Drivers for evidence-based demonstrations across the product life cycle
Pre-launch
Launch and scale
Loss-of-exclusivity (LOE)
Pre-launch

- Unmet needs and disease burden
- Patient recruitment
- Understand the standard of care
- Clinical trial design
Launch & scale

- Patient safety
- Product comparative effectiveness
- Patient adherence
- Prescribing patterns
- Differentiation in sub-populations
- Long-term clinical outcomes
- Target population implications
Loss-of-exclusivity (LOE)

- Effects of switching on outcomes
- Usage differences
- Differentiate with or vs. protected formulation
- For payers to deliver cost-effective care coverage and value for patients’ money.
- For providers to identify better ways to manage patient health.
- For life sciences organizations to make better decisions related to pre-launch, market access, and commercialization.
Axtria’s RWE/HEOR solutions span across the healthcare value spectrum
RWD Expertise

Patient claims

EHR/EMR data

Lab results

Patient registries

Adverse event reporting

Patient-powered research networks (PPRN)
RWE/HEOR Applications Across Domains

Study design

Epidemiology analysis

Real-world comparative analysis

Patient compliance and persistence

Market access and reimbursement strategy

Biomarker analysis

Burden of disease analysis

Drug utilization and patient profiling

Publication and HTA submission support

Budget impact analysis
Read Blog / Quantifying the economic burden of inadequate symptom control among patients with IBS-D
Read Article / RWE In Clinical Trials – Market Trends And Use Cases